Medicine Archives - Page 2 of 5

How Geospatial Mapping Reveals the Impact of Pharmacy Closures

In a video interview with Pharma Commerce, Maggie McCullough, PolicyMap’s CEO, highlights how geospatial mapping can play a critical role

BioNTech, BMS to Co-Design and Co-Commercialize New Antibody Candidate for Various Types of Tumors

Image Credit: Adobe Stock Images/Hugnaka.com Key Takeaways BioNTech and Bristol Myers Squibb have entered a major global collaboration to co-develop

Driving Supply Chain Resilience

In a video interview with Pharma Commerce, Scott Tillman, Logility’s senior vice president of innovation, addresses the gap between high

Greater Supply Chain Prepares for Repercussions

Image Credit: Adobe Stock Images/Somneuk.com Key Takeaways Tariffs could spike drug costs: Proposed 25% tariffs on pharmaceuticals may raise US

Overcoming Legacy Systems

In a video interview with Pharma Commerce, Scott Tillman, Logility’s senior vice president of innovation, addresses the gap between high

Why CX Is a Difference Maker for Pharma

Key Takeaways Exceptional CX significantly boosts engagement with healthcare professionals and consumers, leading to increased prescriptions, better market penetration, and

Bora Expands Baltimore Facility, Adds Automated Fill-Finish Line

Image Credit: Adobe Stock Images/KevinRuck.com Key Takeaways To meet rising demand, Bora Pharmaceuticals is expanding its Baltimore facility by installing

Amplifying Workforce Development

In a video interview with Pharma Commerce, Scott Tillman, Logility’s senior vice president of innovation, addresses the gap between high

Temperature-Sensitive Tech: Cold Chain’s Continuous Development

May 28th 2025 Article Tasked with the delivery of two ultra-sensitive gene therapies to Japan – treatments targeting vision loss

Modeling Shared Decision-Making in Patient Communications

When Coretta learned she had stage 4 non-small cell lung cancer, she was blindsided. She didn’t fit the profile. She

Marken’s Precision Logistics Expedites Delivery of Critical Gene Therapies to Japan

May 28th 2025 Article When a South Korean patient needed a life-changing gene therapy, Marken orchestrated an international distribution strategy

Marken’s Precision Logistics Accelerate Life-Changing Therapy Delivery to Patient in South Korea

May 28th 2025 Article Tasked with the delivery of two ultra-sensitive gene therapies to Japan – treatments targeting vision loss

How Recent Executive Orders Impact the Drug Pricing Landscape

In this exclusive PC Podcast interview, Alice Valder Curran, partner at Hogan Lovells, explores: How recent executive orders—both under the Biden and

Being Digitally Optimized

In a video interview with Pharma Commerce, Scott Tillman, Logility’s senior vice president of innovation, addresses the gap between high

FDA Grants Interchangeability Designation to Hadlima

Image Credit: Adobe Stock Images/PostModernStudio.com Key Takeaways Full interchangeability approved: The FDA has granted full interchangeability to Hadlima for all

Bridging the GenAI Adoption Gap in Supply Chain

In a video interview with Pharma Commerce, Scott Tillman, Logility’s senior vice president of innovation, addresses the gap between high

Mercalis and PharmaCord Officially Merge, Form Valeris

Image Credit: Adobe Stock Images/Feodora.com Main Takeaways The merger of Mercalis and PharmaCord, backed by Permira and Odyssey Investment Partners,

Why It’s Time to Upgrade, and What’s at Stake

The pharmaceutical industry stands at the threshold of a long-overdue transformation in how serialization is approached, implemented, and managed. For

A Strategic Imperative for Biopharma Commercial Success; Advocate for Change to Address Pharmacy Burnout

Navigating the Payer-Health System Nexus: A Strategic Imperative for Biopharma Commercial Success Biopharma companies must adopt integrated strategies that engage

How the Rise of Personalized Medicine Impacts Life Sciences’ Logistics

Key Takeaways Personalized medicine demands precision logistics, with strict temperature control, real-time tracking, and regulatory compliance essential to ensure safe

Balancing Benefits, Risks, and Public Perception with HPV Vaccinations; Pfizer-Backed CellCentric Secures $120M for Further Myeloma Trials

HPV Vaccine: Balancing Benefits, Risks, and Public Perception Despite ongoing lawsuits and public concerns about serious adverse events, current evidence

A Balancing Act

In a video interview with Pharma Commerce, Kevin Dondarski, Deloitte’s life sciences R&D strategy leader, describes how his company’s 15th

The Road to Simpler and Better Clinical Trials; FDA Outlines Stricter Covid Vaccine Booster Standards for Healthy People

Less is More in Clinical Data: The Road to Simpler and Better Trials In an article for Applied Clinical Trials,

Noom to Sell Microdoses of Wegovy

Image Credit: Adobe Stock Images/PeterHansen.com Key Takeaways Noom is now offering its own compounded version of semaglutide—an active ingredient in

The GLP-1 Effect

In a video interview with Pharma Commerce, Kevin Dondarski, Deloitte’s life sciences R&D strategy leader, describes how his company’s 15th

HHS Policy Shift Could Boost Role of Patient Advocates in Clinical Trials

PC: How do you see the potential impact of HHS’s proposed policy change on patient advocacy efforts, particularly for rare

Keeping Drug Supplies Available Means Pharmaceutical Organizations Must Move in Real-Time

Credit: Production Perig | stock.adobe.com Key Takeaways Embrace Real-Time Data for Proactive Supply Chain Management. Advanced manufacturing and real-time analytics

The Role of AI in Solving Clinical Trial Diversity and Access Challenges; FDA Advisors Unanimously Snub Pfizer’s Talzenna in Broader Prostate Cancer Population

The Role of AI in Solving Clinical Trial Diversity and Access Challenges In an interview with Applied Clinical Trials, Michel

Bridging Innovation and Trust with Artificial Intelligence; AstraZeneca Partners with Aptar on Kidney Disease-Detecting AI

Bridging Innovation and Trust with Artificial Intelligence In a recent interview with Applied Clinical Trials, Michel van Harten, MD, CEO

An Exploration of Compounding Practices

Main Takeaways 503B outsourcing facilities must comply with various FDA regulations, including current good manufacturing practices (cGMP), registration, labeling, and

How Digitization Drives End to End Supply Chain Success

PC: How would you define successful E2E, and what specific processes are necessary in order to achieve this? Beadle: The

FDA Outlines Updated Requirement for Placebo-Controlled Trials in Vaccine Research

Image Credit: © JHVEPhoto – stock.adobe.com Key takeaways Placebo-controlled trials now required for low-risk groups: FDA will require placebo-controlled trials

Decreasing Clinical Development Timelines

In a video interview with Pharma Commerce, Kevin Dondarski, Deloitte’s life sciences R&D strategy leader, describes how his company’s 15th

How the Loss of Subsidized Drug Coverage Could Impact Mortality

Image Credit: Adobe Stock Images/Weerasak.com The Low-Income Subsidy, or “Extra Help,” significantly reduces prescription drug costs for 14 million Medicare

Inside Sanofi’s Shift Toward a Data-Driven Supply Chain Model

PC: You recently delivered a keynote presentation surrounding “How to Integrate E2E and Deliver ‘Miracles of Science’ to your Patients.”

Invensify, Go2 Delivery Collaborate on Temperature-Controlled Courier Service

Image Credit: Adobe Stock Images/GorodenKoff.com Invensify and GO2 Delivery’s partnership significantly reduces cold chain packaging costs—by up to 50%—while ensuring

White House Unveils Pharma Most-Favored-Nation Executive Order; FDA, CDC Call for Pause of Chikungunya Shot Rollout in Older Adults

White House Unveils Pharma Most-Favored-Nation Executive Order Pharmaceutical Executive reported that President Trump issued an executive order titled Delivering Most-Favored-Nation

Bluebird Bio Warns of Potential Bankruptcy as Buyout Faces Another Delay; Pharmacists Stockpile Most Common Drugs on Chance of Targeted Trump Tariffs

Bluebird bio warns of potential bankruptcy as buyout faces another delay Bluebird bio has warned of possible bankruptcy after buyers

Five Questions on Trump’s Plan to Lower US Drug Prices; Roche Reports Final Overall Survival Outcomes from Breast Cancer Treatment Trial

Five questions on Trump’s plan to lower US drug prices President Trump’s new plan to lower US drug prices by

A Closer Look at NIH Grant Terminations; Simulated Pre-Launch Market Evaluation in the Modern Pharmaceutical Industry

A Closer Look at NIH Grant Terminations In an interview with Applied Clinical Trials, Harvard Medical School researcher Michael Liu

How to Manage Rising Drug Development Costs

In a video interview with Pharma Commerce, Kevin Dondarski, Deloitte’s life sciences R&D strategy leader, describes how his company’s 15th

Limiting the Use of Spread Pricing

Pharmaceutical Commerce: What specific pricing practice by pharmacy benefit managers (PBMs) does the Protecting Pharmacies in Medicaid Act aim to

Themes Among Rare Disease Repurposing Efforts

Image Credit: Adobe Stock Images/Suriyo.com 1. Five-step repurposing process: The study outlined a five-stage process: enabling, identifying, validating, testing, and

Inside the Daily Workflow of Sanofi’s Global Supply Chain Head

PC: As the head of global supply chain, what does your day-to-day workflow typically consist of? Beadle: Our primary responsibility

UnitedHealth Group CEO Departs

Image Credit: Adobe Stock Images/LucianoLuppa.com 1. Leadership shakeup amid crises: UnitedHealth Group CEO Andrew Witty has abruptly stepped down, citing

The Positive Momentum Behind Pharma Innovation

In a video interview with Pharma Commerce, Kevin Dondarski, Deloitte’s life sciences R&D strategy leader, describes how his company’s 15th

Serialization System SOPs

In a video interview with Pharma Commerce, Michael Rowe, Two Labs’ senior director of DSCSA/serialization compliance services, describes how the

White House Introduces Most Favored Nation EO

Image Credit: Adobe Stock Images/MAlfanSetyawan.com It’s no secret that for years, critics have commented about the prices for medication in

President Trump Announces Most-Favored-Nation Policy for Pharma Prices

On Sunday, President Trump posted to Truth Social that he planned on implementing a most-favored-nation policy for pharmaceutical drug prices.

Piramal Pharma to Invest $90 Million in US Site Expansions

Rendering of the new Lexington sterile fill-finish facility. Image Credit: Piramal Pharma Ltd. Piramal Pharma Limited, a global pharmaceuticals and

Teva Pharmaceutical’s Branded Drugs Boost First Quarter Profit, Theriva Biologics Announces Positive VIRAGE Phase IIb Results

Teva Pharmaceutical’s branded drugs boost first quarter profit Teva Pharmaceutical’s first-quarter profit beat expectations thanks to surging sales of key

Key Takeaways From the 2025 HDA Distribution Management Conference

In a video interview with Pharma Commerce, Michael Rowe, Two Labs’ senior director of DSCSA/serialization compliance services, describes how the

Teva Plots Thousands of Job Cuts as Restructuring Drive Enters ‘Acceleration’ Phase, Takeda to Invest $30B Into US Operations

Teva plots thousands of job cuts as restructuring drive enters ‘acceleration’ phase Teva is set to cut around 2,400 jobs,

Hybrid Hub Models for the Patient Journey

In this video, Josh Marsh, Vice President and General Manager of Cardinal Health Sonexus™ Access and Patient Support, discusses the

Is the Industry Ready for the DSCSA?

In a video interview with Pharma Commerce, Michael Rowe, Two Labs’ senior director of DSCSA/serialization compliance services, describes how the

Measuring What Matters

The latest wave of artificial intelligence (AI), digital health, and direct-to-patient (DTP) models have the potential to drive significant innovation,

Antares Vision Group, Siempharma Strike Up Pharma Labeling Equipment Collaboration

The ETF-300. Image Credit: Antares Vision Group Antares Vision Group, a provider of track-and-trace systems for several fields including the

J&J Survey Finds Pace of Oncology Innovation is Overwhelming Physicians, Biotech is Guessing How Vinay Prasad Might Change the FDA

J&J survey finds pace of oncology innovation is overwhelming physicians A recent J&J survey reveals that oncologists are overwhelmed by

SK Pharmateco Debuts New cGMP Plasmid Suite

Image Credit: Adobe Stock Images/N0m3rcy.com SK pharmteco, a contract development and manufacturing organization (CDMO), has opened a new, 300,000 square-foot

GLP-1 Drugs Reshape Reimbursement and Coverage Models

In an interview with Pharmaceutical Commerce, a session leader from “U.S. Pharmaceutical Transitions: What’s Next?” shared key insights on the current

Digital Health and Biosimilars Shape the Future of Pharmacy

At this year’s Asembia Summit, Pharmaceutical Commerce sat down with Blake Powers, CEO of Medigi, to discuss the company’s role in bridging

Tracking Long-Term Outcomes Key to Advanced Therapy Value

In an interview with Pharmaceutical Commerce, Fran Gregory, VP, emerging therapies, Cardinal Health, shared key insights into the evolving landscape of

Why AI Could Be the Key to Solving Access Challenges in Healthcare

In an interview with Pharmaceutical Commerce, Chip Parkinson, the new CEO of Gift Health, shared his perspective on stepping into the

From Uncertainty to Opportunity: Navigating IPAY 2028

Omar Hafez, SVP of Market Access at Avalere Health, discusses the upcoming changes tied to the Initial Price Applicability Year

Trending Data & Response Plans in the Cleanroom Setting

Being proactive with and responsive to your environmental monitoring (EM) data helps prevent problems with cleanroom contamination. Learn more about

ABM’s Digital Solution for Good Manufacturing Practices

March 14th 2025 Article A regional hospital serving suburban Indianapolis, Hancock Regional Hospital faced a familiar challenge: disparate monitoring systems

Understanding the Inflation Reduction Act

Image Credit: Nicholas Saraceno The afternoon of day 2 at Asembia’s AXS25 Summit offered various intriguing sessions to pick from,

The Medicare Part D Cap and Medicare Prescription Payment Plan

April 30, 2025 Amy Niles, chief mission officer, PAN Foundation, discusses the latest changes to the Medicare program that have

Therapy Advancements Highlight Growing Cost and Access Concerns

In an interview with Pharmaceutical Commerce, Fran Gregory, VP, emerging therapies, Cardinal Health, shared key insights into the evolving landscape

Addressing Polypharmacy Challenges in Europe with Real World Evidence

Multimorbidity and associated polypharmacy, including use of potentially inappropriate medication (PIM), are an increasing challenge for European health systems. A

The Cost of Care for Patients

Image Credit: Nicholas Saraceno The afternoon sessions here on day 3 of Asembia continued its impressive slate, with its various

What Pharma Leaders Must Know About Tariffs, Supply Chains, and Policy Changes

The second day of Asembia’s AXS25 Summit featured a session that addressed a distinct set of challenges facing the pharmaceutical

How Specialty Pharmacies Are Evolving to Support Rare Conditions

In an interview with Pharmaceutical Commerce, Will Pih, co-founder, Two Labs, shared insights from his recent panel discussion on “Economics

Rethinking the Drug Distribution Process

Image Credit: Nicholas Saraceno The final day of education at Asembia’s AXS25 Summit kicked off with a multitude of early

Rare Disease Therapies Drive Shift in Drug Development Focus

In an interview with Pharmaceutical Commerce, a session leader from “U.S. Pharmaceutical Transitions: What’s Next?” shared key insights on the

Navigating the Product Commercialization Process

Image Credit: Nicholas Saraceno Here at Asembia’s AXS25 Summit in Las Vegas, attendees were treated to behind-the-scenes insight regarding “Commercialization

Bridging Health Gaps Through Equity and Education

As the healthcare industry sharpens its focus on patient-centered care, addressing social determinants of health, health equity, and literacy has

Why Distractions Are Detrimental to Business

In a video interview with Pharma Commerce, Paul Levesque, CEO of Theratechnologies, explains how Theratechnologies’ operations have been impacted by

Regeneron, Roche Launch Major US Expansion Plans to Meet Growing Demand for Biologics and Innovation, Trump Assessing Slashing US Drug Prices to International Levels

Regeneron, Roche Launch Major US Expansion Plans to Meet Growing Demand for Biologics and Innovation Regeneron and Roche are investing

Analyzing Tariffs’ Effect on the Biopharmaceutical Supply Chain

In a video interview with Pharma Commerce, Paul Levesque, CEO of Theratechnologies, explains how Theratechnologies’ operations have been impacted by

Understanding True Meaning of Risk in Clinical Trial Operations, European Pharma Companies Push for Higher Drug Prices Amid US Tariff Threats

Understanding the True Meaning of Risk in Clinical Trial Operations In a recent interview with Applied Clinical Trials, Rob Jones

Roche in ‘Very, Very Good Position’ To Weather Trump Tariffs but M&A May Suffer, Thermo Fisher to Invest Addlitional $2 Billion In US To Boost Manufacturing

Roche in ‘Very, Very Good Position’ To Weather Trump Tariffs but M&A May Suffer Roche expects to weather the financial

Will Moving Drug Production to the United States Help or Hurt Patients?

In a video interview with Pharma Commerce, Paul Levesque, CEO of Theratechnologies, explains how Theratechnologies’ operations have been impacted by

Fast-Tracking the Future

Claire Riches highlights inefficiencies in the current drug approval process, while outlining the role of payers and insurers in shifting

The Future of Specialty Medicine

In a video interview with Pharma Commerce, Paul Levesque, CEO of Theratechnologies, explains how Theratechnologies’ operations have been impacted by

PCI to Purchase Full Stake in Ajinomoto Althea

Image Credit: Business Wire PCI Pharma Services, a contract development and manufacturing organization (CDMO), will be purchasing a full stake

IATA CEIV Celebrates a Decade of Enhancing Air Cargo Efficiency

Image Credit: Adobe Stock Images/OMS.com The International Air Transport Association (IATA) is celebrating 10 years of its Center of Excellence

Three Ways to Turn Sustainability Pledges Into Progress

PC: How can stakeholders ensure that sustainability takes precedence, even over other important business drivers? Ganguly: There are three key

Reducing Polypharmacy in Older Adults

Image Credit: Adobe Stock Images/Kotchakorn.com Among the older population, polypharmacy—the use of five or more medications—has skyrocketed. The issue lies

Driving Business Success Through Sustainability

PC: You just wrapped up a panel discussion on “Uniting on Sustainability: How can we drive collaboration and ground-breaking initiatives

Preparing for DSCSA Deadlines

In a video interview with Pharma Commerce, Jody Hatcher, CEO of Morris & Dickson and chair of HDA’s board of

Thermo Fisher Scientific Unveils Advanced Therapies Collaboration Center

Image Credit: Thermo Fisher Scientific Thermo Fisher Scientific has officially opened its Advanced Therapies Collaboration Center (ATxCC) in Carlsbad, CA.1

Why Patient Empowerment is Key

In a video interview with Pharma Commerce, Rachel Thorpe, executive director at the Otsuka Patient Assistance Foundation, discusses two key

Pharma Companies Expected to Absorb Any Tariff Hit in Short Term, New Chronic Antigen Exposure Data, & more

Pharma companies expected to absorb any tariff hit in short term While US tariffs on pharmaceuticals may eventually raise drug

FDA Grants Interchangeability Designation to Celltrion’s Humira Biosimilar Yuflyma

Image Credit: Adobe Stock Images/Monchisa The FDA has granted interchangeability designation to Celltrion’s Yuflyma (adalimumab-aaty), a high-concentration (100 mg/mL), citrate-free

Bringing Biotech Innovation Across Borders, Role of Collaboration in Advancing Rare Disease Research

Bringing Biotech Innovation Across Borders A feature published by Pharmaceutical Executive authored by Ed Ahn, CEO of MEDIPOST, Inc, outlines

The Quest to Deliver Reliability

In a video interview with Pharma Commerce, Jody Hatcher, CEO of Morris & Dickson and chair of HDA’s board of

Lessons from Life Sciences and Beyond

For a child with autism spectrum disorder (ASD), effective care coordination across the required medical, physical rehabilitation, counseling, occupational, and

The Real Work Behind the Annual Program

PC: How do you manage to keep the program itinerary organized year after year? Robinson: While we have a broader

Leading with Purpose

In a video interview with Pharma Commerce, Jody Hatcher, CEO of Morris & Dickson and chair of HDA’s board of

Pharma Leaders Prioritize Artificial Intelligence and Sustainability

PC: When comparing this year to previous years, how would you say the main discussion points of LogiPharma have evolved?

Meribel Pharma Solutions Joins the CDMO Marketplace

Image Credit: Adobe Stock Images/Metamorworks.com There is a new contract development and manufacturing organization (CDMO) in the marketplace. With the

LogiPharma to Move to Vienna for Sustainability and Focused Sessions

PC: What was the thought process behind moving LogiPharma to Vienna in 2026? Robinson: First and foremost, it’s about the

April 2025 Interactive Digital Edition

Pharmaceutical Commerce: April 2025 Interactive Digital Edition The Cold Chain’s Evolution Tariffs Galore: Where Do We Stand? Conference Connect: Progressing

An AI-Pharma Transport Collaboration

Logistics play a very important role in the pharmaceutical industry, as the activities involved are highly sensitive to time and

The Role of CDMOs in the Pharma Cold Chain Machine

The pharmaceutical cold chain sector plays a crucial role in ensuring the safe and effective delivery of temperature-sensitive medications, including

The Evolving Role of Operations in Advancing Therapeutic Delivery

PC: What general advice do you have for other pharma supply chain stakeholders when it comes to delivering change that

Long-Term Sustainability for Diverse Trial Initiatives, Payers Consider Policy Options for GLP-1 Access & more

Long-Term Sustainability for Diverse Trial Initiatives LaShell Robinson, head of global feasibility and trial equity at Takeda, discusses how Takeda

Hubs East 2025: Building a Thriving Culture

In a video interview with Pharma Commerce, Kimberly Westrich, MD, chief strategy offer at the National Pharmaceutical Council, describes how

Harnessing Technology to Advance Operations and Patient Impact

PC: How can technology play a role in implementing these changes, and what challenges can it help overcome? Lang: Technology

Four Ways to Increase Speed to Therapy

Let’s start with an alarming pair of statistics. First, 40% of specialty product prescriptions actually get filled, and second, when

What Your Data Can Tell You About Illicit Trade Risk

One of the objections I sometimes hear when discussing counterfeiting and diversion challenges with pharmaceutical manufacturers, particularly smaller ones, is

Healthcare Scorecard from Patients with Chronic Illness

Healthcare costs, insurance barriers, and medical debt are preventing patients with chronic illnesses in the US from accessing essential treatments

Popping the Gross-to-Net Bubble, Part III: The Pharmacy Benefit

Welcome to the third installment of my “Popping the Gross-to-Net Bubble” series. In my previous column, I explored actionable steps

Reevaluating One’s CGT Value Chain

Image Credit: Nicholas Saraceno LogiPharma Europe continued its star-studded lineup featuring Big Pharma, with a morning keynote case study on

US Drug Price Negotiations and Transparency

When I was penning my latest column for Pharma Commerce, I felt that various recent developments were worth noting, considering

Maintaining R&D Investments in the IRA Era

Developing effective lifesaving drugs requires significant research and development (R&D) investments. New medications cost an average of $2.3 billion to

GenAI’s Real Impact on Life Sciences Manufacturing

The COVID-19 pandemic highlighted our supply chains’ weaknesses like never before. A sudden surge in demand and limited production capabilities

How Various Programs Affect Patient Care and Health Equity

In a video interview with Pharma Commerce, Kimberly Westrich, MD, chief strategy offer at the National Pharmaceutical Council, describes how

Boehringer Ingelheim Opens $31.5 Million Oncology Antibody-Drug Conjugate Facility in Switzerland

Image Credit: Adobe Stock Images/MichaelVi Boehringer Ingelheim announced the official opening of a new antibody-drug conjugate (ADC) research and development

Balancing Cost-Efficiency with Domestic Manufacturing Need, Making M3P Work for Your Pharmacy & more

Balancing Cost-Efficiency with the Need for Domestic Manufacturing Marcel Botha, CEO of 10XBeta, discusses finding a balance between the need

Analyzing the Theranos Appeals, Current CAR-T Therapy Trends in Managed Care & more

Analyzing the Theranos Appeals Matthew Yelovich, partner at Cleary Gottlieb, discusses the appeals of Elizabeth Holmes and Ramesh “Sunny” Balwani

Establishing and Transitioning to a Foundation

In a video interview with Pharma Commerce, Rachel Thorpe, executive director at the Otsuka Patient Assistance Foundation, discusses two key

The ‘Healthy Immigrant Effect’, Google Gemini, AI Commercialization in Pharma & more

Google Gemini, AI Commercialization in Pharma and More Google recently released an updated version of its AI LLM. Gemini 2.5

Reasons Behind the Rising Popularity of DTC Online Prescription Services

In a video interview with Pharma Commerce, Colin Banas, MD, DrFirst’s chief medical officer, describes have many Americans face significant

Siemens Inks $5.1 Billion Deal for Dotmatics

Image Credit: Adobe Stock Images/Tun.com Siemens AG, a technology conglomerate, has acquired Dotmatics, an R&D scientific software company, from private

The Growing Role of DTC Healthcare

In a video interview with Pharma Commerce, Colin Banas, MD, DrFirst’s chief medical officer, describes have many Americans face significant

Trump Issues New Reciprocal Tariffs

Image Credit: Adobe Stock Images/Bashirlrshad.com Yesterday afternoon, as reported by AP,1 US President Donald Trump announced that he will be

Understanding Copay Accumulators, Maximizers, and Alternative Funding Programs

In a video interview with Pharma Commerce, Kimberly Westrich, MD, chief strategy offer at the National Pharmaceutical Council, describes how

Hims & Hers Begins Selling Zepbound

Image Credit: Adobe Stock Images/Douglas.com A Reuters report1 noted that Hims & Hers began selling various Eli Lilly drugs on

The Financial Barrier to GLP-1s

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Colin Banas, MD, DrFirst’s chief medical

DHL Purchases Cryoport’s Specialty Courier

Oscar de Bok, CEO of DHL Supply Chain, and Jerrell Shelton, CEO of Cryoport. Image Credit: DHL Supply Chain DHL

Balancing Technology, Personalization, and Human Connection in Patient Support

PC: What are some of the biggest challenges in ensuring continued medication adherence for specialty patients? Butler: While technology and

Embarking on the CAR-T Journey

Renier Brentjens, MD, PhD outlines the evolution of the space, while offering ways to boost patient access to these treatments.

Singota Solutions Opens New Plant in Balerna, Switzerland

Image Credit: Singota Solutions Following the launch of last year’s site in Rovello Porro, Italy,1 Singota Solutions, a contract development

How Engagement Strategies Are Evolving in Specialty Pharmacy

PC: How is the role of patient engagement evolving in specialty pharmacy? Butler: It’s becoming increasingly critical to evolve patient

The Role of Emotional Support in Improving Patient Adherence

PC: What are some common barriers patients face when starting specialty medications, and how can peer-to-patient outreach help? Butler: Our

LillyDirect Platform to Help Provide Alzeheimer’s Support

Image Credit: Adobe Stock Images/Orawan.com Eli Lilly and Company is growing its LillyDirect digital healthcare platform to offer independent in-person and

Hubs East 2025: Navigating Specialty Medication Onboarding

PC: How does Pleio’s GoodStart program assist specialty pharmacies in improving patient engagement and adherence? Butler: Onboarding onto specialty medications

Balancing Technological & Human Support in Medication Access, How PBMs’ Vertical Integration Impacts Health Care & more

Balancing Technological & Human Support in Medication Access Kimberley Chiang, vice president of biopharma commercial solutions at CoverMyMeds, addresses patient

Futureproofing Pharma Supply Chains

In a video interview with Pharma Commerce, Brad Stewart, BDO’s national life sciences co-leader, describes the challenges that tariffs may

Examining Healthcare Spending Across US Counties

Image Credit: Adobe Stock Images/Gaming.com Although the United States spends an exorbitant amount on healthcare, amounts across the individual states

The Unfinished Work of Healthcare Reform

Charitable donations have long been a vital lifeline for patients struggling to afford life-saving medications, particularly those with chronic and

Protecting Temperature-Sensitive Pharmaceuticals, Without Unnecessary Plastic Waste

Advances in the life sciences are driving a significant increase in the number of temperature-sensitive pharmaceuticals. The packaging industry is

Spreading Awareness of Medicare Part D Reforms

Image Credit: Nicholas Saraceno Informa’s Access USA conference from Philadelphia continued with its first panel discussion of the conference. Amy

How Charitable Programs Are Evolving to Improve Patient Access to Life-Saving Medications

Charitable donations have long been a vital lifeline for patients struggling to afford life-saving medications, particularly those with chronic and

New Ways of Targeting Cancer, How Employers Can Support Employee Well-Being and Mental Health & more

New Ways of Targeting Cancer Company executives provide updates on cancer treatment pelareorep and other elements of the company’s pipeline.

The Biggest Bottlenecks for Patients, Age and Comorbidities Drive RSV Hospitalization Rates & more

The 2025 Medication Access Report: Biggest Bottlenecks for Patients Kimberley Chiang, vice president of biopharma commercial solutions at CoverMyMeds, highlights

The Ongoing Challenge for Nonprofit Patient Assistance Programs

Charitable donations have long been a vital lifeline for patients struggling to afford life-saving medications, particularly those with chronic and

PAP 2025: Boosting Patient Empowerment

Image Credit: Nicholas Saraeno Day 2 of Informa’s Access USA track-based coverage carried on, with an afternoon session on the

PAP 2025: Understanding the Uninsured Landscape

Image Credit: Nicholas Saraceno Day 2 of Informa’s Access USA conference represented the start of its track-based sessions. In terms

The Impact of Out-of-Pocket Costs on Patients with Rare Diseases

Charitable donations have long been a vital lifeline for patients struggling to afford life-saving medications, particularly those with chronic and

Access USA 2025: Uncovering Patient Access Complexities

Image Credit: Nicholas Saraceno Informa’s Access USA conference leveraged its KOL base with a roundtable on “Unravelling the Complexities of

How Charitable Programs Are Evolving to Improve Patient Access to Life-Saving Medications

Charitable donations have long been a vital lifeline for patients struggling to afford life-saving medications, particularly those with chronic and

This Year’s State of the Industry

Image Credit: Nicholas Saraceno Day 1 of Informa’s Access USA Conference from Philadelphia—featuring Patient Assistance & Access Programs (PAP) and

How Pharma Leaders Can Secure Supply Chains

In a video interview with Pharma Commerce, Brad Stewart, BDO’s national life sciences co-leader, describes the challenges that tariffs may

The Impact of Automation on Costs and Variability

In a video interview with Pharma Commerce, Jason C. Foster, CEO of Ori Biotech, describes how the current state of

Building Adaptability in the Pharmaceutical Industry

It’s no secret that the pharmaceutical industry is facing a myriad of challenges and disruption, such as complex, costly, and

Hancock Health Case Study: Pharmacy Temperature Monitoring

March 14th 2025 Article Transitioning from manual temperature logs and reactive power outage management to a comprehensive cloud-based monitoring solution,

Sonicu and Pharmacy Stars help hospital-based pharmacy with a powerful software integration

November 21st 2024 Article The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals.

How Sonicu supports remote clinics and pharmacists with a 24/7 cloud-based remote monitoring solution

March 14th 2025 Article A regional hospital serving suburban Indianapolis, Hancock Regional Hospital faced a familiar challenge: disparate monitoring systems

Pre-Launch Prep for Emerging Biopharmas, Using the Power of Three to Simplify the Business of Healthcare & more

Pre-Launch Prep for Emerging Biopharmas: Data First, Then the Rest Making early commercial data and analytics decisions for launch cen

Cold Chain Technologies Inks Deal for Global Cold Chain Solutions

Image Credit: Adobe Stock Images/WatermillStudio.com Cold Chain Technologies (CCT), a US-based provider of thermal packaging and digital monitoring solutions for the transportation of

Breaking Down Regulatory Challenges in Cell Therapy Production

In a video interview with Pharma Commerce, Jason C. Foster, CEO of Ori Biotech, describes how the current state of

Navigating Internal Constraints and Uncertainty

In a video interview with Pharma Commerce, Brad Stewart, BDO’s national life sciences co-leader, describes the challenges that tariffs may

Syngene Purchases First US Manufacturing Facility for $36.5M

In a transaction officially set to close later this month, Syngene International Limited, a contract research, development, and manufacturing organization

Overcoming Bottlenecks in Personalized Medicine Manufacturing

In a video interview with Pharma Commerce, Jason C. Foster, CEO of Ori Biotech, describes how the current state of

PharmaCord, Mercalis Merge in an Effort to Support the Patient Journey

Image Credit: Adobe Stock Images/Mrzproducer.com PharmaCord LLC, a provider of patient services for the biopharmaceutical industry, and Mercalis, a life

President Trump to Double Tariffs on Canadian Steel and Aluminum

Image Credit: Adobe Stock Images/Ketsara.com On Tuesday morning, as reported by AP,1 US President Trump announced that the original tax

Unlocking the Potential of Cell and Gene Therapies

In a video interview with Pharma Commerce, Jason C. Foster, CEO of Ori Biotech, describes how the current state of

Strategic Trends in Pharmaceutical Manufacturing for Industry Leaders

The pharmaceutical manufacturing sector is experiencing a profound transformation driven by technological advancements, regulatory shifts, and market dynamics. Industry leaders

The Case for Reshoring Manufacturing to the United States

In a video interview with Pharma Commerce, Brad Stewart, BDO’s national life sciences co-leader, describes the challenges that tariffs may

Tariff Impact on Medication Availability/Accessibility for Telehealth Patients, Addressing the Gap in Type 1 Diabetes Care & more

Potential Tariff Impact on Availability & Accessibility of Medications for Telehealth Patients In this Pharmaceutical Executive Video Interview, Peter Ax,